ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 122 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $207,000 | -48.2% | 50,102 | +1.4% | 0.00% | -50.0% |
| Q3 2016 | $400,000 | +4.4% | 49,403 | +0.5% | 0.01% | +100.0% |
| Q2 2016 | $383,000 | -1.8% | 49,152 | -2.6% | 0.00% | 0.0% |
| Q1 2016 | $390,000 | -29.0% | 50,486 | -0.7% | 0.00% | -25.0% |
| Q4 2015 | $549,000 | +61.0% | 50,854 | +3.0% | 0.00% | +33.3% |
| Q3 2015 | $341,000 | -26.0% | 49,370 | -5.2% | 0.00% | +50.0% |
| Q2 2015 | $461,000 | -43.7% | 52,083 | -37.3% | 0.00% | -60.0% |
| Q1 2015 | $819,000 | +2308.8% | 83,045 | +702.0% | 0.01% | – |
| Q1 2014 | $34,000 | -85.4% | 10,355 | -63.7% | 0.00% | -100.0% |
| Q2 2013 | $233,000 | – | 28,519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |